Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled rhDNase for acute asthma in children
NL-OMON29109Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in asthma comparing Dornase alfa + standard care with Placebo + standard care (2 arms). Primary endpoint: Improvement in asthma score 1 hour after intervention. Started Sep 2005; status: active, not recruiting.
02
Drugs
dornase alfa
03
Conditions
asthma
Beyond the preview
Go deeper on NL-OMON29109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29109.